Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer

CONCLUSION: Moderate hypofractionated PBT may be a useful radiotherapy method for centrally located cT1-T4N0M0 NSCLC.PMID:37097674 | DOI:10.21873/anticanres.16361

https://pubmed.ncbi.nlm.nih.gov/37097674/?utm_source=no_user_agent&utm_medium=rs...

Source: Cancer Control - April 25, 2023 Category: Cancer & Oncology Authors: Masatoshi Nakamura Hitoshi Ishikawa Kayoko Ohnishi Keiichiro Baba Taisuke Sumiya Motohiro Murakami Yuichi Hiroshima Masashi Mizumoto Toshiyuki Okumura Hideyuki Sakurai Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Proton Therapy